Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
15 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Vrijwillige ontbinding – vereffening according to the CBE.
Financials
Financial year 2025
Vesalius Biocapital II ARKIV from Zaventem, company number BE0838376938, closed financial year 2025 with a result of € -16,121 after tax. For that financial year Vesalius Biocapital II ARKIV recorded a gross margin of € -33,705 and equity of € 1.6 million. Compared with financial year 2024, the result moved from € -32,780 to € -16,121. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.
€ 1.6 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -16,121
▲ 51 % less loss than in 2024
Profit after tax over the fiscal year.
€ 78,356
▼ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -11.9 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,262
▼ 87% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -11,803 | € -32,620 | € -32,423 | € -33,705 | ▼ € 1,282 |
| Profit after taxes | € -11,886 | € -33,110 | € -32,780 | € -16,121 | ▲ € 16,659 |
| Equity | € 2,520,860 | € 2,487,750 | € 1,646,436 | € 1,630,315 | ▼ 1% |
| Total debts | € 8,448 | € 448 | € 50,779 | € 6,262 | ▼ 88% |
| Cash | € 192,129 | € 151,019 | € 138,994 | € 78,356 | ▼ 44% |
| Retained profit | € -10,978,215 | € -11,011,325 | € -11,852,639 | € -11,868,760 | |
| Balance sheet total | € 2,529,308 | € 2,488,198 | € 1,697,215 | € 1,636,577 | ▼ 4% |
Key figures of Vesalius Biocapital II ARKIV, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Vesalius Biocapital II ARKIV?
What happened at Vesalius Biocapital II ARKIV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
Vesalius Biocapital II ARKIV is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.
- New annual accounts for financial year 2025: loss of € 16,121. Source: NBB ↗
- VESALIUS BIOCAPITAL II PARTNERS SARL became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Brussel. KBO
In short
From € 11,886 loss in 2021 to € 16,121 loss in 2025.
A new publication or filing at Vesalius Biocapital II ARKIV? We notify you, reason included.
Follow Vesalius Biocapital II ARKIVDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Participatiemaatschappij Vlaanderen comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Vesalius Biocapital II ARKIVBehind Vesalius Biocapital II ARKIV is VESALIUS BIOCAPITAL II PARTNERS SARL. The shares are held by Participatiemaatschappij Vlaanderen (49.9%). It owns 22.9% of TROD MEDICAL and 15.2% of AMAKEM itself.
Directors
According to the 2025 annual accounts
VESALIUS BIOCAPITAL II PARTNERS SARL
Liquidator · represented by Stéphane VERDOOD
since 2021
Shareholders
Participations
22.9%
15.2%
Establishments
Establishment units
Physical locations of this company
Lenneke Marelaan 8
1932 Zaventem
Hertogsstraat 67 box 6
1000 Brussel
Active since 3 August 2011
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.
All companies at this address →GRUNENTHAL
€ 39.3 million revenue · 2025
Belgian Recorded Music Association
SIMIM Société de l'Industrie Musicale - Muziekindustrie Maatschappij
IMAGIA
ALMA COURT INVEST
+10 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0838.376.938
- VAT number
- BE 0838.376.938
- Registered office
- Lenneke Marelaan 8, 1932 Zaventem
- Names & denominations
- Vesalius Biocapital II ARKIV
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Vrijwillige ontbinding – vereffening
- Start date
- 5 August 2011
- Peppol
- Not registered